RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.46B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$163M
2
+$141M
3
+$105M
4
LENZ
LENZ Therapeutics
LENZ
+$93.3M
5
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$71M

Top Sells

1
+$704M
2
+$164M
3
+$94M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$93.6M
5
INBX
Inhibrx, Inc. Common Stock
INBX
+$73.2M

Sector Composition

1 Healthcare 99.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$31.1M 0.4%
+2,180,631
52
$30.6M 0.39%
2,082,021
-1,971,056
53
$30.1M 0.38%
5,755,050
+247,703
54
$24M 0.31%
+1,529,988
55
$21.3M 0.27%
+1,385,491
56
$20.1M 0.26%
+861,573
57
$20M 0.25%
+15,384,615
58
$19.9M 0.25%
800,000
59
$19.4M 0.25%
+938,591
60
$19.2M 0.24%
2,033,056
61
$19.1M 0.24%
1,281,000
62
$18.4M 0.23%
+2,024,221
63
$18.4M 0.23%
+1,744,415
64
$18.4M 0.23%
+1,750,000
65
$18M 0.23%
5,551,295
66
$18M 0.23%
+6,250,000
67
$17.9M 0.23%
3,525,754
68
$17.7M 0.23%
+7,541,000
69
$17.4M 0.22%
421,348
70
$10.4M 0.13%
+660,938
71
$9.33M 0.12%
8,800,000
72
$9.05M 0.12%
937,500
73
$6.58M 0.08%
791,359
-494,641
74
$5.96M 0.08%
1,965,707
-778,563
75
$4.79M 0.06%
347,069
1 2
3
4